SCHEMBL27844867

SCHEMBL27844867

C=CC(c1ccc(-c2ccccc2)cc1)S(=O)(=O)Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.40
▸ CYP17A1 P05093 1/20 0.39
▸ ACP3 P15309 2/20 0.38
▸ PTGS2 P35354 2/20 0.38
▸ GRIA4 P48058 1/20 0.37
▸ CA1 P00915 3/20 0.37
▸ CA2 P00918 3/20 0.37
▸ CA9 Q16790 3/20 0.37
▸ CA12 O43570 2/20 0.37
▸ CA14 Q9ULX7 1/20 0.37
▸ CHRNB2 P17787 1/20 0.36
▸ CHRNA4 P43681 1/20 0.36
▸ OPRD1 P41143 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ APAF1 O14727 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1173054 0.89 HSD17B10 (0.38) CYP3A4MEN1LMNAMAPTKMT2A
SCHEMBL27275837 0.79 MAPK1 (0.37) CYP3A4CA1CA2CA9CA12
SCHEMBL27979918 0.78 TLR9 (0.36) CYP3A4GRIA4CA1CA2CA9
SCHEMBL28793737 0.78 IDO1 (0.32) CA1CA2
SCHEMBL27556761 0.76 UGT2B7 (0.41) CYP3A4CA1CA2CA9MEN1
SCHEMBL28795710 0.75 TGM2 (0.40) CYP3A4PTGS2MEN1LMNAKMT2A
SCHEMBL27844721 0.74 GRIA4 (0.41) CYP3A4GRIA4CA1CA2CA9
SCHEMBL27857728 0.74 HSD11B1 (0.38) ACP3CA1CA2CA9
SCHEMBL776436 0.72 CYP2C19 (0.38) CYP3A4LMNAMAPT
SCHEMBL27862042 0.71 TRPV4 (0.39) CYP3A4LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102292319-A Novel substituted octahydrocyclopenta(C)pyrrol-4-amines as calcium channel blockers — 2011-12-21 — — CN disclosed
Send feedback